Cabergoline for Preventing Breast Symptoms After Abortion or Pregnancy Loss
This study is looking at whether a medication called cabergoline can help prevent breast symptoms like engorgement and milk leakage after an abortion or pregnancy loss. These symptoms can happen because the body starts to prepare for breastfeeding even with a pregnancy loss. Participants will receive either a single dose of cabergoline or a placebo (a pill with no active medicine) about an hour after their procedure. Researchers want to see if cabergoline reduces the number of people who experience breast symptoms and how severe those symptoms are. You might be able to join if you are 18 or older, 12 to 18 weeks pregnant, and having an abortion or pregnancy loss at Maimonides Medical Center. The study is currently unclear about its recruitment status and plans to enroll 348 participants.
- Study design
- This is an interventional study where participants will be randomly assigned to receive either cabergoline or a placebo. The study plans to enroll 348 participants.
- What's involved
- Participants will receive a single oral dose of medication approximately one hour after their procedure. They will also need to complete study surveys.
- Compensation
- Not stated in the trial record.
- Follow-up
- Researchers will measure breast symptoms 4 days after the abortion or pregnancy loss.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- June Ng, MD · PRINCIPAL_INVESTIGATOR · Maimonides Medical Canter
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Proportion of Participants With Breast Symptoms 4 Days After Abortion or Pregnancy Loss4 days after abortion or pregnancy loss
The proportion of participants reporting any breast symptoms, including breast engorgement, milk leakage, tenderness, or need for pain relief, assessed using the Bristol Breast Symptoms Inventory.